|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1990-8-8
|
|
pubmed:abstractText |
We have assessed the efficacy and safety of imipenem/cilastatin in a non-comparative study of 27 immunocompromised patients suffering from severe bacterial infections. Moreover in two groups of 14 patients the efficacy of imipenem/cilastatin versus a standard broad spectrum antibiotic therapy has also been compared. Clinical and microbiological efficacy and side effects have been evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1120-009X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
100-7
|
|
pubmed:dateRevised |
2009-8-4
|
|
pubmed:meshHeading |
pubmed-meshheading:2193998-Adolescent,
pubmed-meshheading:2193998-Adult,
pubmed-meshheading:2193998-Aged,
pubmed-meshheading:2193998-Bacterial Infections,
pubmed-meshheading:2193998-Cilastatin,
pubmed-meshheading:2193998-Drug Synergism,
pubmed-meshheading:2193998-Drug Therapy, Combination,
pubmed-meshheading:2193998-Endocarditis, Bacterial,
pubmed-meshheading:2193998-Female,
pubmed-meshheading:2193998-Humans,
pubmed-meshheading:2193998-Imipenem,
pubmed-meshheading:2193998-Male,
pubmed-meshheading:2193998-Middle Aged,
pubmed-meshheading:2193998-Prospective Studies,
pubmed-meshheading:2193998-Randomized Controlled Trials as Topic,
pubmed-meshheading:2193998-Urinary Tract Infections
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections.
|
|
pubmed:affiliation |
L. Spallanzani Hospital, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
